Clinical trials
Phase 1/2 Acquired Immunodeficiency Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Unknown status | 7 |
| Recruiting | 6 |
| Terminated | 6 |
| Withdrawn | 3 |
| Not yet recruiting | 3 |
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 5 |
| Beijing 302 Hospital | 3 |
| Erasmus Medical Center | 3 |
| International AIDS Vaccine Initiative | 3 |
| Jiangsu Aidea Pharmaceutical Group Co., Ltd. | 3 |
| National Cancer Institute (NCI) | 3 |
| Diane George | 2 |
| International Partnership for Microbicides, Inc. | 2 |
| Janssen Vaccines & Prevention B.V. | 2 |
| Yale University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 66 |
| HIV Infections | 17 |
| Infections | 4 |
| Sarcoma, Kaposi | 4 |
| Lymphoma | 3 |
| Substance-Related Disorders | 3 |
| AIDS Dementia Complex | 2 |
| Anemia, Aplastic | 2 |
| Anemia, Diamond-Blackfan | 2 |
| Anemia, Sickle Cell | 2 |
Trials
Showing 76 to 66 of 66. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.